04:26 AM EDT, 04/17/2026 (MT Newswires) -- Trevi Therapeutics ( TRVI ) said late Thursday it priced its public offering of 11.6 million common shares at $13 each for about $150 million in gross proceeds.
Underwriters have a 30-day overallotment option to purchase up to 1.74 million additional shares.
The company expects the offering to close by Monday.
Trevi shares were down 4.5% in premarket activity Friday.